Xiao-Mei Tang
Overview
Explore the profile of Xiao-Mei Tang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
293
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhai P, Chen M, Wang Q, Zhao J, Tang X, Lu C, et al.
Front Oncol
. 2025 Mar;
15:1509810.
PMID: 40078192
Background: Growing evidence indicates that abnormal liquid-liquid phase separation (LLPS) can disrupt biomolecular condensates, contributing to cancer development and progression. However, the influence of LLPS on the prognosis of head...
2.
Tang X, Shi M, Wang J, Gu Y, Dai Y, Yang Q, et al.
Cell Biosci
. 2025 Feb;
15(1):17.
PMID: 39920847
Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive and often lethal malignancy, requiring the development of enhanced therapeutic approaches. The DNA damage response (DDR) pathway is frequently altered during PDAC...
3.
Zhuang S, Bao Z, Tang X, Xiang J, Mo C, Zhong S
BMC Neurol
. 2024 Dec;
24(1):476.
PMID: 39643903
Objective: Anti-IgLON5 disease is a rare autoimmune mediated disease. It is mainly featured by sleep-related disturbance, parkinsonism, chorea and limb ataxia. Previous studies had clarified its clinical manifestations and predisposing...
4.
Tang H, Cao Y, Zhou Y, Ma Y, Jiang H, Zhang H, et al.
J Adv Res
. 2024 Jan;
67():253-267.
PMID: 38244773
Background: Pancreatic cancer, referred to as the "monarch of malignancies," is a neoplastic growth mostly arising from the epithelial cells of the pancreatic duct and acinar cells. This particular neoplasm...
5.
Zhang M, Jiang L, Liu X, Liu F, Zhang H, Zhang Y, et al.
Heliyon
. 2024 Jan;
10(1):e24287.
PMID: 38234923
Pancreatic adenocarcinoma (PAAD) remains challenging to diagnose and treat clinically due to its difficult early diagnosis, low surgical resection rate, and high risk of postoperative recurrence and metastasis. SMAD4 is...
6.
Wang Y, Tang X, Jiang R, Sun Y, Liu Q, Zhang P, et al.
Pacing Clin Electrophysiol
. 2023 Dec;
47(1):167-171.
PMID: 38041413
Background: Atrial esophageal fistula (AEF) is a lethal complication that can occur post atrial fibrillation (AF) ablation. Esophageal injury (EI) is likely to be the initial lesion leading to AEF....
7.
Liu S, Liu S, Tang X, Liu X, Yang J, Cui G, et al.
Phys Chem Chem Phys
. 2023 Oct;
25(41):28452-28464.
PMID: 37846460
Herein, we have employed a combination of the optimally tuned screened range-separated hybrid (OT-SRSH) functional, the polarizable continuum model (PCM), and nonadiabatic dynamics (NAMD) simulations to investigate the photoinduced dynamics...
8.
Cao Y, Ding J, Tang Q, Zhang J, Huang Z, Tang X, et al.
Bioengineered
. 2023 Apr;
13(7-12):14974-14986.
PMID: 37105769
A tumor's heterogeneity has important implications in terms of its clonal origin, progression, stemness, and drug resistance. Therefore, because of its significance in treatment, it is important to understand the...
9.
Li S, Xue P, Diao X, Fan Q, Ye K, Tang X, et al.
J Adv Res
. 2023 Jan;
54:133-146.
PMID: 36716957
Background: Aberrations in MYC underlie a large proportion of liver hepatocellular carcinoma (LIHC) cases; however, MYC is difficult to target because of its undruggable structure. We aimed to uncover MYC-associated...
10.
Yu X, Liu J, Tang Q, Diao X, Fan Q, Huang Z, et al.
Ann Med
. 2022 Nov;
54(1):2785-2795.
PMID: 36370068
Background: Improvements in screening and imaging technologies and treatment of liver disease have influenced the trend in diagnosis for stage I liver cancer. In this article, recent trends in age,...